The Journal of Urology
Volume 175, Issue 4 , Pages 1353-1358 , April 2006

Efficacy and Safety of Histrelin Subdermal Implant in Patients With Advanced Prostate Cancer

  • Peter N. Schlegel

      Affiliations

    • Financial interest and/or other relationship with Valera Pharmaceuticals.
    • Corresponding Author InformationCorrespondence: Starr 900, Department of Urology, New York Presbyterian Hospital-Weill Cornell Medical Center, 525 East 68th St., New York, New York 10021 (telephone: 212-746-5491; FAX: 212-746-8425)
  • ,
  • Histrelin Study Group

Received 15 December 2004

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by a grant from Valera Pharmaceuticals.

PII: S0022-5347(05)00649-X

doi: 10.1016/S0022-5347(05)00649-X

The Journal of Urology
Volume 175, Issue 4 , Pages 1353-1358 , April 2006